Glenmark Life Sciences IPO price band fixed at Rs 695-720, to raise Rs 1,513.6 crore

Glenmark Life IPO: The IPO comprises a fresh issue of Rs 1,060 crore and an offer for sale of 63 lakh equity shares by promoter Glenmark Pharmaceuticals ‘); $ (‘#lastUpdated_’+articleId).text(resData[stkKey][‘lastupdate’]); //if(resData[stkKey][‘percentchange’] > 0){ // $ (‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”); // $ (‘.arw_red’).removeClass(“arw_red”).addClass(“arw_green”); //}else if(resData[stkKey][‘percentchange’] = 0){ $ (‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”); //$ (‘.arw_red’).removeClass(“arw_red”).addClass(“arw_green”); $ (‘#gainlosstxt_’+articleId).find(“.arw_red”).removeClass(“arw_red”).addClass(“arw_green”); }else if(resData[stkKey][‘percentchange’] 0) { var resStr=”; […]

Continue Reading

GR Infraprojects spikes 120% on listing day; what should investors do now?

Given the stellar debut, experts advise short-term investors to book profits. However, long-term investors can hold the stock. New investors, or existing investors looking to add to their position, should wait for a more opportune time, they say. Sunil Shankar Matkar July 19, 2021 / 03:14 PM IST Representative image ‘); $ (‘#lastUpdated_’+articleId).text(resData[stkKey][‘lastupdate’]); //if(resData[stkKey][‘percentchange’] > […]

Continue Reading

Tatva Chintan IPO subscribed 180.35 times on final day, NII portion booked 512.22 times

Tatva Chintan IPO: The company shares traded at a premium of Rs 700-750 in the grey market at time of writing this copy ‘); $ (‘#lastUpdated_’+articleId).text(resData[stkKey][‘lastupdate’]); //if(resData[stkKey][‘percentchange’] > 0){ // $ (‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”); // $ (‘.arw_red’).removeClass(“arw_red”).addClass(“arw_green”); //}else if(resData[stkKey][‘percentchange’] = 0){ $ (‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”); //$ (‘.arw_red’).removeClass(“arw_red”).addClass(“arw_green”); $ (‘#gainlosstxt_’+articleId).find(“.arw_red”).removeClass(“arw_red”).addClass(“arw_green”); }else if(resData[stkKey][‘percentchange’] 0) { var resStr=”; var url = ‘//www.moneycontrol.com/mccode/common/saveWatchlist.php’; […]

Continue Reading

Tatva Chintan IPO subscribed 138.5 times on final day, NII portion booked 407.4 times

Tatva Chintan IPO: The company shares traded at a premium of Rs 700-750 in the grey market at time of writing this copy ‘); $ (‘#lastUpdated_’+articleId).text(resData[stkKey][‘lastupdate’]); //if(resData[stkKey][‘percentchange’] > 0){ // $ (‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”); // $ (‘.arw_red’).removeClass(“arw_red”).addClass(“arw_green”); //}else if(resData[stkKey][‘percentchange’] = 0){ $ (‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”); //$ (‘.arw_red’).removeClass(“arw_red”).addClass(“arw_green”); $ (‘#gainlosstxt_’+articleId).find(“.arw_red”).removeClass(“arw_red”).addClass(“arw_green”); }else if(resData[stkKey][‘percentchange’] 0) { var resStr=”; var url = ‘//www.moneycontrol.com/mccode/common/saveWatchlist.php’; […]

Continue Reading

Clean Science Technology stock ends 76% higher on listing day; time to book profits?

Despite the better-than-expected listing gains, experts advise remaining invested in the stock for the long-term given the company’s strong financials and fundamentals, international presence, and leading position in several critical products. Sunil Shankar Matkar July 19, 2021 / 04:20 PM IST ‘); $ (‘#lastUpdated_’+articleId).text(resData[stkKey][‘lastupdate’]); //if(resData[stkKey][‘percentchange’] > 0){ // $ (‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”); // $ (‘.arw_red’).removeClass(“arw_red”).addClass(“arw_green”); //}else if(resData[stkKey][‘percentchange’] […]

Continue Reading

Clean Science jumps 76% to close at Rs 1,585.20 on listing day

Siddhartha Khemka of Motilal Oswal expects Clean Science to do well post listing, given the huge response to the IPO, robust financials and a growing demand for companies in green chemicals ‘); $ (‘#lastUpdated_’+articleId).text(resData[stkKey][‘lastupdate’]); //if(resData[stkKey][‘percentchange’] > 0){ // $ (‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”); // $ (‘.arw_red’).removeClass(“arw_red”).addClass(“arw_green”); //}else if(resData[stkKey][‘percentchange’] = 0){ $ (‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”); //$ (‘.arw_red’).removeClass(“arw_red”).addClass(“arw_green”); $ (‘#gainlosstxt_’+articleId).find(“.arw_red”).removeClass(“arw_red”).addClass(“arw_green”); }else if(resData[stkKey][‘percentchange’] […]

Continue Reading

GR Infraprojects has a big-bang start, surges 109% on debut day

The Rs 963-crore public issue of the road engineering, procurement and construction company was subscribed 102.58 times ‘); $ (‘#lastUpdated_’+articleId).text(resData[stkKey][‘lastupdate’]); //if(resData[stkKey][‘percentchange’] > 0){ // $ (‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”); // $ (‘.arw_red’).removeClass(“arw_red”).addClass(“arw_green”); //}else if(resData[stkKey][‘percentchange’] = 0){ $ (‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”); //$ (‘.arw_red’).removeClass(“arw_red”).addClass(“arw_green”); $ (‘#gainlosstxt_’+articleId).find(“.arw_red”).removeClass(“arw_red”).addClass(“arw_green”); }else if(resData[stkKey][‘percentchange’] 0) { var resStr=”; var url = ‘//www.moneycontrol.com/mccode/common/saveWatchlist.php’; $ .get( “//www.moneycontrol.com/mccode/common/rhsdata.html”, function( data ) […]

Continue Reading

Tatva Chintan IPO oversubscribed by 10.55 times on Day 2, retail portion booked 18.34 times

The specialty chemical company opened its IPO for subscription on July 16. It was subscribed 4.5 times on the first day of bidding. ‘); $ (‘#lastUpdated_’+articleId).text(resData[stkKey][‘lastupdate’]); //if(resData[stkKey][‘percentchange’] > 0){ // $ (‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”); // $ (‘.arw_red’).removeClass(“arw_red”).addClass(“arw_green”); //}else if(resData[stkKey][‘percentchange’] = 0){ $ (‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”); //$ (‘.arw_red’).removeClass(“arw_red”).addClass(“arw_green”); $ (‘#gainlosstxt_’+articleId).find(“.arw_red”).removeClass(“arw_red”).addClass(“arw_green”); }else if(resData[stkKey][‘percentchange’] 0) { var resStr=”; var url = ‘//www.moneycontrol.com/mccode/common/saveWatchlist.php’; […]

Continue Reading

#39;Don#39;t expect significant listing gains in Zomato, investors should exit once the initial euphoria ends#39;

Seeing the excitement from institutional investors to subscribe to the IPO, the issue is expected to get oversubscribed multiple times. Sunil Shankar Matkar July 16, 2021 / 09:12 AM IST ‘); $ (‘#lastUpdated_’+articleId).text(resData[stkKey][‘lastupdate’]); //if(resData[stkKey][‘percentchange’] > 0){ // $ (‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”); // $ (‘.arw_red’).removeClass(“arw_red”).addClass(“arw_green”); //}else if(resData[stkKey][‘percentchange’] = 0){ $ (‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”); //$ (‘.arw_red’).removeClass(“arw_red”).addClass(“arw_green”); $ (‘#gainlosstxt_’+articleId).find(“.arw_red”).removeClass(“arw_red”).addClass(“arw_green”); }else if(resData[stkKey][‘percentchange’] 0) […]

Continue Reading

Zomato will be a long-term compounding story instead of multibagger one: Vinit Bolinjkar of Ventura Securities

The companies, like Zomato, who are reporting negative EBITDA but has a strong top-line should be valued at an enterprise value (EV) to sales, which is a globally accepted valuation metric. Sunil Shankar Matkar July 16, 2021 / 11:15 AM IST ‘); $ (‘#lastUpdated_’+articleId).text(resData[stkKey][‘lastupdate’]); //if(resData[stkKey][‘percentchange’] > 0){ // $ (‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”); // $ (‘.arw_red’).removeClass(“arw_red”).addClass(“arw_green”); //}else if(resData[stkKey][‘percentchange’] […]

Continue Reading

Tatva Chintan Pharma Chem IPO subscribed 4.50 times on Day 1

Tatva Chintan Pharma Chem IPO gets a subscribe rating from Anand Rathi, which is positive on the company’s long-term prospects ‘); $ (‘#lastUpdated_’+articleId).text(resData[stkKey][‘lastupdate’]); //if(resData[stkKey][‘percentchange’] > 0){ // $ (‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”); // $ (‘.arw_red’).removeClass(“arw_red”).addClass(“arw_green”); //}else if(resData[stkKey][‘percentchange’] = 0){ $ (‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”); //$ (‘.arw_red’).removeClass(“arw_red”).addClass(“arw_green”); $ (‘#gainlosstxt_’+articleId).find(“.arw_red”).removeClass(“arw_red”).addClass(“arw_green”); }else if(resData[stkKey][‘percentchange’] 0) { var resStr=”; var url = ‘//www.moneycontrol.com/mccode/common/saveWatchlist.php’; $ .get( “//www.moneycontrol.com/mccode/common/rhsdata.html”, […]

Continue Reading

Subscribe to Tatva Chintan Pharma Chem: Anand Rathi

Anand Rathi has come out with its report on Tatva Chintan Pharma Chem. The research firm has recommended to ”Subscribe” the ipo in its research report as on July 15, 2021. Broker Research July 16, 2021 / 01:53 PM IST ‘); $ (‘#lastUpdated_’+articleId).text(resData[stkKey][‘lastupdate’]); //if(resData[stkKey][‘percentchange’] > 0){ // $ (‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”); // $ (‘.arw_red’).removeClass(“arw_red”).addClass(“arw_green”); //}else if(resData[stkKey][‘percentchange’] = […]

Continue Reading

Tatva Chintan IPO: Parvati Rai of KRChoksey explains why the issue got fully subscribed within hours

Strong financials, growth potential, dominant position and potential play on green chemistry has helped Tatva Chintan IPO garner huge interest Parvati Rai July 17, 2021 / 09:59 AM IST ‘); $ (‘#lastUpdated_’+articleId).text(resData[stkKey][‘lastupdate’]); //if(resData[stkKey][‘percentchange’] > 0){ // $ (‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”); // $ (‘.arw_red’).removeClass(“arw_red”).addClass(“arw_green”); //}else if(resData[stkKey][‘percentchange’] = 0){ $ (‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”); //$ (‘.arw_red’).removeClass(“arw_red”).addClass(“arw_green”); $ (‘#gainlosstxt_’+articleId).find(“.arw_red”).removeClass(“arw_red”).addClass(“arw_green”); }else if(resData[stkKey][‘percentchange’] 0) { […]

Continue Reading

Subscribe to Tatva Chintan Pharma Chem: KR Choksey

KR Choksey has come out with its report on Tatva Chintan Pharma Chem. The research firm has recommended to ”Subscribe” the ipo in its research report as on July 15, 2021. Broker Research July 16, 2021 / 02:00 PM IST ‘); $ (‘#lastUpdated_’+articleId).text(resData[stkKey][‘lastupdate’]); //if(resData[stkKey][‘percentchange’] > 0){ // $ (‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”); // $ (‘.arw_red’).removeClass(“arw_red”).addClass(“arw_green”); //}else if(resData[stkKey][‘percentchange’] = […]

Continue Reading

Subscribe to Tatva Chintan Pharma Chem: Motilal Oswal

Motilal Oswal has come out with its report on Tatva Chintan Pharma Chem. The research firm has recommended to ”Subscribe” the ipo in its research report as on July 15, 2021. Broker Research July 16, 2021 / 02:14 PM IST ‘); $ (‘#lastUpdated_’+articleId).text(resData[stkKey][‘lastupdate’]); //if(resData[stkKey][‘percentchange’] > 0){ // $ (‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”); // $ (‘.arw_red’).removeClass(“arw_red”).addClass(“arw_green”); //}else if(resData[stkKey][‘percentchange’] = […]

Continue Reading

Tatva Chintan Pharma Chem IPO shares trade at 60% premium in grey market as the issue opens

The specialty chemical company is planning to raise Rs 500 crore through public issue which comprises a fresh issue of Rs 225 crore and an offer for sale of Rs 275 crore by promoter and promoter group. ‘); $ (‘#lastUpdated_’+articleId).text(resData[stkKey][‘lastupdate’]); //if(resData[stkKey][‘percentchange’] > 0){ // $ (‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”); // $ (‘.arw_red’).removeClass(“arw_red”).addClass(“arw_green”); //}else if(resData[stkKey][‘percentchange’] = 0){ $ (‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”); […]

Continue Reading

Subscribe to Tatva Chintan Pharma Chem: Hem Securities

Hem Securities has come out with its report on Tatva Chintan Pharma Chem. The research firm has recommended to ”Subscribe” the ipo in its research report as on July 15, 2021. Broker Research July 16, 2021 / 02:33 PM IST ‘); $ (‘#lastUpdated_’+articleId).text(resData[stkKey][‘lastupdate’]); //if(resData[stkKey][‘percentchange’] > 0){ // $ (‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”); // $ (‘.arw_red’).removeClass(“arw_red”).addClass(“arw_green”); //}else if(resData[stkKey][‘percentchange’] = […]

Continue Reading

Tatva Chintan Pharma Chem IPO opens today: Should you subscribe?

On account of strong growth potential, dominant manufacturer status, potential play on ‘green chemistry’ and discounted valuation compared to its peers, KR Choksey recommended a ‘subscribe’ rating for long term gains for Tatva Chintan IPO. Sunil Shankar Matkar July 16, 2021 / 08:12 AM IST ‘); $ (‘#lastUpdated_’+articleId).text(resData[stkKey][‘lastupdate’]); //if(resData[stkKey][‘percentchange’] > 0){ // $ (‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”); // […]

Continue Reading

Tatva Chintan Pharma Chem mobilises Rs 150 crore from anchor investors ahead of IPO

Axis MF, Aditya Birla Sun Life, Nippon Life, SBI Life Insurance,, SBI MF, ICICI Prudential, and HDFC Trustee are among domestic investors invested in Tatva Chintan through anchor book. ‘); $ (‘#lastUpdated_’+articleId).text(resData[stkKey][‘lastupdate’]); //if(resData[stkKey][‘percentchange’] > 0){ // $ (‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”); // $ (‘.arw_red’).removeClass(“arw_red”).addClass(“arw_green”); //}else if(resData[stkKey][‘percentchange’] = 0){ $ (‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”); //$ (‘.arw_red’).removeClass(“arw_red”).addClass(“arw_green”); $ (‘#gainlosstxt_’+articleId).find(“.arw_red”).removeClass(“arw_red”).addClass(“arw_green”); }else if(resData[stkKey][‘percentchange’] 0) { […]

Continue Reading

Zomato IPO | Anita Gandhi of Arihant Capital on why the offer is a long-term play

A large untapped population, changing food habits of the new generation and more women joining the workforce augur well for the company in the long term, says Gandhi Sunil Shankar Matkar July 15, 2021 / 10:38 AM IST ‘); $ (‘#lastUpdated_’+articleId).text(resData[stkKey][‘lastupdate’]); //if(resData[stkKey][‘percentchange’] > 0){ // $ (‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”); // $ (‘.arw_red’).removeClass(“arw_red”).addClass(“arw_green”); //}else if(resData[stkKey][‘percentchange’] = 0){ $ […]

Continue Reading